Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND: Safety of STS101 in Acute Migraine
NCT04406649Phase 3Completed
- Start
- Sep 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroergotamine in migraine. Started Sep 2020; status: completed.
02
Drugs
dihydroergotamine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04406649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406649.